脑卒中后发作患者的结果:系统性审查和元分析
Shubham Misra1, Scott E Kasner2, Jesse Dawson3
1Division of Stroke & Vascular Neurology, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
JAMA neurology
|September 18, 2023
概括
脑卒中后发作 (PSSs) 在中风幸存者中显著增加死亡率和残疾. 特别是早期发作与较高的死亡率有关,这凸显了预防发作研究的必要性.
科学领域:
- 神经学 神经学
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- 关于中风后发作 (PSSs) 对患者结局的影响存在不一致的数据.
- 需要对PSS对中风患者结果的影响进行系统评估.
研究的目的:
- 调查和比较PSS患者与没有PSS患者的结果.
- 系统地评估PSS对中风患者结果的影响.
主要方法:
- 一个系统的审查和对报告PSS结果的观察性研究的元分析.
- 在多个数据库 (MEDLINE,Embase等) 进行了搜索. 从1951年开始到2023年1月.
- 使用PRISMA检查清单和Joanna Briggs研究所的数据提取和偏差风险评估工具;使用随机效应元分析分析数据.
主要成果:
- 包括71篇文章,超过20,000名患有PSS的患者和100多万没有PSS的患者.
- PSS与增加的死亡率 (OR,2.1),较差的功能结果 (OR,2.2),较大的残疾 (SMD,0.6) 和痴呆风险 (OR,3.1) 有关.
- 早期发作与较高的死亡率和不良结果有关,影响了缺血性和出血性中风亚型.
结论:
- 脑卒中后发作与中风患者的死亡率增加和严重残疾显著相关.
- 对这些关联的进一步研究是临床和研究的优先事项.
- 可能需要进行临床试验,研究预防中风后发作的干预措施.
相关概念视频
Seizures: Classification
406
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
406
Arteries of the Lower Limbs
212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339


